What Actually Happens When a Company Sells You Stock

When a company "goes public," most investors picture a straightforward sale of shares to the crowd, but the real mechanics run through underwriters, institutional roadshows, and a pricing process that structurally favors large clients over retail buyers. Understanding that path explains why IPOs so often pop on day one, and why retail investors rarely capture the pop.

By Karanvir Singh, founder of Quantix Invest

The core principle: primary versus secondary markets

Companies raise capital through primary market transactions, in which brand-new securities are created and sold directly to investors, with the proceeds flowing to the issuing company. This is entirely distinct from the secondary market, where existing securities change hands between investors every trading day, and where the company itself receives nothing from any given trade regardless of the price. When you buy a share of a well-established public company through your brokerage account, you are almost always participating in the secondary market: your money goes to whoever sold you the share, not to the company.

A private company going public works with one or more underwriters, typically large investment banks, who evaluate the company, help set an offering price, and formally buy the newly issued shares from the company before reselling them to investors. This underwriting relationship is the hinge on which the entire process turns, because the underwriter's incentives, guaranteeing a successful sale while managing its own risk, shape almost every subsequent decision about pricing and allocation.

Underwriting itself typically takes one of two forms. In a firm commitment deal, the underwriter buys the entire offering from the company at the agreed price and bears the risk of reselling it to investors, absorbing any loss if demand falls short. In a best efforts deal, more common for smaller or riskier offerings, the underwriter simply agrees to try to sell as much of the offering as possible without guaranteeing the company will receive the full amount it hoped to raise. The distinction matters because it determines who bears the risk that an offering is poorly received: in a firm commitment deal that risk sits with the underwriter, which is one reason underwriters price these deals conservatively in the first place.

The issuance process, step by step

The process typically begins with the company filing detailed disclosure documents with securities regulators, describing its business, financials, and risks. The underwriter then conducts a roadshow, a series of presentations to large institutional investors, mutual funds, pension funds, hedge funds, to gauge demand and collect indications of interest at various possible prices. Based on that feedback, the underwriter and company agree on a final offering price, set deliberately to be attractive enough that the underwriter can confidently place all the shares, which in practice usually means pricing conservatively relative to what public market demand can actually bear once trading begins.

Shares are then allocated, overwhelmingly to the large institutional clients who participated in the roadshow, with only a small fraction, if any, typically reaching individual retail investors before the stock begins trading publicly on an exchange. Once trading opens, the price is set by ordinary buy and sell orders in the secondary market, and it is entirely possible, common even, for that opening trade to sit well above the original offering price.

Beyond a traditional IPO, companies raise additional capital through secondary offerings, selling more new shares after already being public, and through rights offerings, giving existing shareholders the option to buy additional shares, often at a discount, in proportion to their current holdings. A company might also raise debt capital through the bond market's primary offerings rather than issuing new equity at all, a choice that depends on the company's existing leverage, its cost of debt versus equity, and how much dilution its existing shareholders are willing to accept. Each of these paths involves its own underwriting process, though generally with less of the roadshow drama associated with a first-time public offering, since an already-public company has an established trading history and price the market can reference directly.

The math: who actually captures the IPO pop

Worked example one: the basic mechanics. A company agrees to sell 10 million shares to its underwriter at an offering price of 18 dollars each, raising 10,000,000 x 18 = 180 million dollars for the company. The underwriter allocates the bulk of those shares to institutional clients at that same 18 dollar price. If public demand is strong once trading opens, the stock might begin trading at 25 dollars, a first-day gain of (25 − 18) / 18 = 38.9 percent. That gain belongs entirely to whoever held shares at the 18 dollar offering price, almost always institutions, not to retail investors, who can typically only buy at the 25 dollar opening trade or higher. The company still only ever received its original 180 million dollars; the first-day pop does not add a single dollar to its balance sheet.

Worked example two: the retail investor's actual position. Suppose a retail investor buys 100 shares at the 25 dollar opening trade, an outlay of 2,500 dollars. If the stock settles back down to 22 dollars by the end of its first week, a common pattern as initial excitement fades, the retail investor's position is worth 100 x 22 = 2,200 dollars, a loss of (2,200 − 2,500) / 2,500 = 12 percent in a matter of days, even though the IPO was widely reported as a resounding success with a nearly 39 percent first-day pop. The institutional investor who received shares at 18 dollars and sold into the day-one rally at 25 dollars still walks away with a real, locked-in gain regardless of what happens afterward.

What the historical record shows

Across many decades and thousands of offerings, the empirical pattern of IPO underpricing, where the opening public trading price sits meaningfully above the offering price, has been remarkably persistent, showing up across different market environments, exchanges, and eras, though the average size of the pop has varied considerably by period and by sector. A second well-documented pattern is that IPO stocks, on average, have gone on to underperform comparable already-public companies over the subsequent one to three years following the offering, a finding that has held up across multiple independent studies using different methodologies and time periods, even though any individual IPO can and does defy the average in either direction. Neither pattern implies IPOs are uniformly bad investments, some go on to become excellent long-term holdings, but together they argue against treating the fact of a successful, hyped IPO as itself a signal of a good entry price for a retail investor buying at the open.

Researchers studying underpricing have proposed several explanations, none of which fully accounts for the pattern alone. One view holds that underwriters deliberately underprice to reward loyal institutional clients and ensure strong first-day demand, protecting the underwriter's own reputation for successful deals. Another view emphasizes information asymmetry: the company and its underwriter know more about the business than public market investors do, and a degree of underpricing compensates institutional investors for the uncertainty of buying into a security with a limited public track record. Whatever the precise mix of causes, the consistency of the pattern across so many decades and market environments is itself the most useful takeaway for an ordinary investor deciding how to treat IPO hype.

How this should shape a real investor's approach

For most individual investors, the practical implication is straightforward: participating in an IPO at the actual offering price is rarely accessible, and buying at the opening public trade means paying a price that has already absorbed the pop that made headlines, without any of the informational advantage the institutional allocation holders had. A more disciplined approach treats a newly public company the way you would treat any unfamiliar stock, waiting for at least one or two full quarterly earnings reports to see how the business actually performs as a public company, subject to the ordinary scrutiny and disclosure requirements that a roadshow's curated narrative does not fully capture. High earners with access to certain brokerage IPO allocation programs should understand that even preferential retail access typically comes with a smaller allocation and less favorable terms than institutional clients receive.

It is also worth distinguishing IPO investing from investing in an already-established public company issuing new shares through a secondary offering. The latter has a real trading history, real audited financial statements covering multiple quarters or years, and a market price already tested through ordinary supply and demand, all of which give an investor considerably more information to work with than a company's first appearance on public markets. This is not a reason to avoid IPOs altogether, but it is a reason to treat the due diligence bar for a brand-new public company as meaningfully higher than for one with an established track record.

Actionable breakdown

• Understand the flow of money:
  • Only the primary offering price reaches the company.
  • Day-one trading gains flow to early institutional holders.
• Before buying a new IPO, check:
  • The offering price versus the current trading price.
  • The underwriter and the size of the retail allocation, if any.
• Consider waiting:
  • Let the post-IPO volatility settle before buying.
  • Review at least one full earnings report as a public company.

Common pitfalls

Retail investors frequently buy newly public stocks at the inflated opening trade, effectively paying for the pop rather than capturing it. A second pitfall is assuming a rising stock price after the IPO reflects fresh capital reaching the business, when secondary market trading, the overwhelming majority of daily volume for any stock, sends no money to the company at all. A third mistake is treating a heavily hyped IPO as a signal of underlying quality rather than recognizing it as, in part, a marketing and pricing exercise managed by underwriters with their own incentives. A fourth is ignoring lockup expirations, dates when early investors and employees become free to sell, which can create meaningful selling pressure months after the IPO that has nothing to do with the company's fundamentals. A fifth is confusing a firm commitment underwriting with a best efforts deal, assuming a company is guaranteed to receive its full targeted proceeds when the underwriting structure may not actually promise that.

The bottom line

New securities move from company to underwriter to institutions before ordinary investors ever see them, which is why the most attractive IPO pricing is structurally reserved for the institutional clients who receive the initial allocation, and why patience usually serves a retail investor better than urgency on opening day. Treat the first earnings report or two as the real test of the company rather than the roadshow narrative or the first-day headlines, since audited results under public-market scrutiny reveal far more than a marketing pitch ever will.

Related reading: IPOs and speculation, how securities are traded, equity securities, intrinsic value versus market price.

All articles · The deep guides